Guru Ownership Trend
Guru Analysis for Bicycle Therapeutics plc (BCYC)
Bicycle Therapeutics plc (BCYC), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $7.45 M.
Top institutional holders include Renaissance Technologies (RenTech) and Louis Moore Bacon.
Institutional sentiment is currently Bullish. This is evidenced by a $2.43 M net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 56.6%. Conversely, Murray Stahl reduced exposure by 4.6%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Bicycle Therapeutics plc (BCYC)
Major holders include Renaissance Technologies (RenTech) ($6.5 M), Louis Moore Bacon ($1.17 M), Steven Cohen ($635,729). According to the latest reported data, 4 tracked investment managers collectively hold approximately 1.97 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $2.43 M, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited BCYC. The total reported sell value was $2,560.95.
Yes, 0 managers opened new positions in BCYC, and 2 increased their existing holdings. The total reported buy value was $2.43 M.